Sung Lee Tango Therapeutics, Inc. (TNGX) insider trading activity

TNGX Quotes by TradingView

Sung Lee is of Tango Therapeutics, Inc.. Currently has a direct ownership of 10,000 shares of TNGX, which is worth approximately $81,700. The most recent transaction as insider was on Jan 02, 2026, when has been sold 10,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10K
n/a 3M change
n/a 12M change
Total Value Held $81,700

Sung Lee Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2026
BUY
Grant, award, or other acquisition
-
10,000 Added 50.0%
10,000 Common Stock

Also insider at

SGMO
SANGAMO THERAPEUTICS, INC Healthcare
EVP, Chief Financial Officer
VIR
Vir Biotechnology, Inc. Healthcare
EVP & Chief Financial Officer
CYTK
CYTOKINETICS INC Healthcare
EVP, Chief Financial Officer
SL

Sung Lee

Brisbane, CA

Track Institutional and Insider Activities on TNGX

Follow Tango Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TNGX shares.

Notify only if

Insider Trading

Get notified when an Tango Therapeutics, Inc. insider buys or sells TNGX shares.

Notify only if

News

Receive news related to Tango Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TNGX